Inhibiteurs de xanthine oxydase et procédés d'utilisation

Xanthine oxidase inhibitors and methods of use

Abstract

L'invention concerne des inhibiteurs de la xanthine oxydase, ainsi que des compositions, des procédés pour leur utilisation dans le traitement de troubles, induits au moins en partie, par la xanthine oxydase.
Xanthine oxidase inhibitors are provided, as well as compositions, methods for their use for treating disorders, mediated at least in part, by xanthine oxidase.

Claims

Description

Topics

Download Full PDF Version (Non-Commercial Use)

Patent Citations (5)

    Publication numberPublication dateAssigneeTitle
    US-4803225-AFebruary 07, 1989Fisons, PlcDihydroxy-phenethylamino compounds useful as pharmaceuticals
    US-5399577-AMarch 21, 1995Taiho Pharmaceutical Co., Ltd.Isoxazole derivatives and salts thereof
    US-6121303-ASeptember 19, 2000Orion-Yhtyma OyPharmacologically active catechol derivatives
    US-6169092-ADecember 31, 1969
    US-6169092-B1January 02, 2001Bayer Aktiengesellschaft3-Ureido-pyridofurans and -pyridothiophenes for the treatment of inflammatory processes

NO-Patent Citations (2)

    Title
    DATABASE PubChem 5 December 2007 (2007-12-05), Database accession no. 22112903
    LU ET AL.: "3,4-Dihydroxy-5-nitrobenzaldehyde (DHNB) is a Potent Inhibitor of Xanthine Oxidase: a potential therapeutic agent for treatment of hyperuricemia and gout", BIOCHEM PHARMACOL., vol. 86, no. 9, 2013, pages 22, XP028741420, DOI: doi:10.1016/j.bcp.2013.08.011

Cited By (0)

    Publication numberPublication dateAssigneeTitle